Boiler Room: The Official Stock Market Discussion

[chineebai]

SKIN - above $23 on a closing basis would be good. jmo

100% on options, out of options. Still have some commons, raise stops to 23, next level should be $24.70 if it can close there then around $26.50, imo.

 

[chineebai]

Coty is a long term stock for me as I've posted a out it many times before. Check out the monthly chart and if it can break 10 next is 15 on the monthly. Imo.

 

[winb83]

You TTCF brehs kill me I legit dont get the appeal of this company but I hope it works out for yall

ADSK with a hard fall in AH, currently sitting at 319 from 344 high yesterday. Earnings were good though.

The appeal is growth.

 

[jerzboy]

Coty is a long term stock for me as I've posted a out it many times before. Check out the monthly chart and if it can break 10 next is 15 on the monthly. Imo.

reading into that company now

 

[chineebai]

There's a gap on the spy at 443.70. watching that level of 445 support breaks

 

[El_Mero_Mero]

Does everybody here have things set up to automatically reinvest dividends? If not, why?

 

[dora_da_destroyer]

What's the worst investment yal made in the market this last year?

Mines gotta be jumping into the EV parts hype and buying warrants for VLDR (Velodyne Lidar) when it was $12.50 and CPSH when it was $18...


As of today VLDRW is down 84.80% and trading at $1.88 and CPSH is down 68% and trading at $5.76


Bought both at damn near the worst time

some shyty SPAC warrants...almost let myself chase the weed stock run, glad i didn't

 

[choc_cardigan]

$CBDD is my worst play so far

 

[humminbird]

Worst play this year is definitely sos

 

[humminbird]

Coty is a long term stock for me as I've posted a out it many times before. Check out the monthly chart and if it can break 10 next is 15 on the monthly. Imo.

Yeah I have it as a long term hold as well

 

[humminbird]

Peloton is getting hammered in after hours
Lowering the price of the bike though
Looks like the “elite” are going to have find a new flex toy

 

[jerzboy]

SAN DIEGO, Nov. 1, 2019 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) announced today new data demonstrating that suppression of NR2F6 using patent-pending compounds developed by the Company results in selective inhibition of new blood vessels under conditions associated with cancer and wet macular degeneration. The data, which was obtained using human umbilical vein endothelial cells (HUVEC), indicates that NR2F6 may have a larger biological role than originally suspected.' data-reactid="12">SAN DIEGO, Nov. 1, 2019 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) announced today new data demonstrating that suppression of NR2F6 using patent-pending compounds developed by the Company results in selective inhibition of new blood vessels under conditions associated with cancer and wet macular degeneration. The data, which was obtained using human umbilical vein endothelial cells (HUVEC), indicates that NR2F6 may have a larger biological role than originally suspected.

Regen BioPharma, Inc. has been utilizing NR2F6 as a target for immune modulation and cancer stem cells. To the Company's knowledge, this is the first indication to date that NR2F6 is involved in the formation of new blood vessels.

Thomas Ichim, PhD, co-inventor of the patent and consultant to the Company. "In our experiments, we observed that inhibition of NR2F6 selectively blocked multiplication of blood vessel cells that were stimulated with Vascular Endothelial Growth Factor (VEGF). Since VEGF is associated with disease conditions, it is possible that our approach possesses some degree of specificity in blocking pathological but not healthy formation of new blood vessels. New blood vessels suggests that this approach may not suppress healthy blood vessels which are primarily formed independently of VEGF."' data-reactid="14">"New blood vessels are typically not formed in an adult except in conditions such as cancer (in which the tumor cells require a new blood supply) or in wet macular degeneration; a condition in which new blood vessels result in impairment of vision," said Thomas Ichim, PhD, co-inventor of the patent and consultant to the Company. "In our experiments, we observed that inhibition of NR2F6 selectively blocked multiplication of blood vessel cells that were stimulated with Vascular Endothelial Growth Factor (VEGF). Since VEGF is associated with disease conditions, it is possible that our approach possesses some degree of specificity in blocking pathological but not healthy formation of new blood vessels. New blood vessels suggests that this approach may not suppress healthy blood vessels which are primarily formed independently of VEGF."

$2.8 Billion in 20181) for cancer and Lucentis (Sales $1.9 Billion in 20182).' data-reactid="15">Drugs which target VEGF as a means of suppressing pathological blood vessel formation include Avastin (Sales $2.8 Billion in 20181) for cancer and Lucentis (Sales $1.9 Billion in 20182).

David Koos. "We believe this coupled with our current small molecule therapies as a quality additional approach to treating cancer."" data-reactid="16">"What this data demonstrates is a potential mechanism to kill cancer cells without the toxicity associated with conventional treatments," noted the Company's Chairman & CEO David Koos. "We believe this coupled with our current small molecule therapies as a quality additional approach to treating cancer."






Yahoo is now part of Verizon Media


Its cheap af, so I have over a million shares here. When AMRN gets over $20, I prolly stop buying and start building up RGBP again. They are still in Phase 1/2, so its def a long term play, but I don't mind the risk. They recently announced some shyt reducing, or preventing RI.



Heres the other link:

Regen BioPharma Successfully Treats Rheumatoid Arthritis Using Cannabidiol (CBD) Based Immune Modulatory Treatments


Im heavy AF in Biotech right now. Ill take a look into those companies he listed for sure.

holding them now.. again I’ve never played the pennys but I’m rolling the dice with this. Bought a bunch of shares and have been waiting fir another dip. Doesn’t look like it’s going to happen so I’m going to buy a bunch more in the morning. Thanks bruh

 

[KING WILL]

holding them now.. again I’ve never played the pennys but I’m rolling the dice with this. Bought a bunch of shares and have been waiting fir another dip. Doesn’t look like it’s going to happen so I’m going to buy a bunch more in the morning. Thanks bruh

Yw bro!

 

[chineebai]

Super tricky tape leading up to the Fed symposium tomorrow. Very choppy. Lots of doom n gloom from the mainstream. Price is news, nothing else. Cancel outside noises.

 

[ahomeplateslugger]

PTON earnings was pretty solid despite the recall and stoppage from selling their equipment. despite those factors, they still increased subscribers quarter over quarter, their revenue was good and they're building a peloton facility in USA that should be done by 2023. i'm long PTON so might be biased but this could be a good buying opportunity.